Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kenichi Fukumoto
Observed names:
K Fukumoto,
Ken-ichi Fukumoto
Institutions:
Taisho Pharmaceutical (Japan),
Sumitomo Dainippon Pharma (Japan)
Observed institutions:
Taisho Pharmaceutical (Japan),
Tokyo University of Pharmacy and Life Sciences,
Sumitomo Dainippon Pharma (Japan),
Yale University
OpenAlex ID:
A5109448594
Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine
2017
·
Kenichi Fukumoto
, Hidetoh Toki
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
273
Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2 R ,6 R )-hydroxynorketamine
2018
·
Kenichi Fukumoto
, Manoela V. Fogaça
, et al.
·
Proceedings of the National Academy of Sciences
·
204
PDF
The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN
2015
·
Kenichi Fukumoto
, Michihiko Iijima
, et al.
·
Neuropsychopharmacology
·
193
Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test
2014
·
Kenichi Fukumoto
, Michihiko Iijima
, et al.
·
Psychopharmacology
·
107
Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression
2012
·
Hiroyuki Koike
, Kenichi Fukumoto
, et al.
·
Behavioural Brain Research
·
98
Role of 5-HT1A Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine
2017
·
Kenichi Fukumoto
, Michihiko Iijima
, et al.
·
The International Journal of Neuropsychopharmacology
·
96
PDF
BDNF release and signaling are required for the antidepressant actions of GLYX-13
2017
·
T Kato
, M V Fogaça
, et al.
·
Molecular Psychiatry
·
94
N-Methyl-D-aspartate receptor antagonist d-methadone produces rapid, mTORC1-dependent antidepressant effects
2019
·
Manoela V. Fogaça
, Kenichi Fukumoto
, et al.
·
Neuropsychopharmacology
·
86
PDF
Acute and sustained effects of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test
2012
·
Michihiko Iijima
, Kenichi Fukumoto
, et al.
·
Behavioural Brain Research
·
68
Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT1A receptor stimulation
2020
·
Kenichi Fukumoto
, Manoela V. Fogaça
, et al.
·
Neuropsychopharmacology
·
59
PDF
Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP 0233278 and TASP 0390325
2014
·
M Iijima
, T Yoshimizu
, et al.
·
British Journal of Pharmacology
·
56
5-HT1A receptor stimulation in the medial prefrontal cortex mediates the antidepressant effects of mGlu2/3 receptor antagonist in mice
2018
·
Kenichi Fukumoto
, Michihiko Iijima
, et al.
·
Neuropharmacology
·
34
mGlu receptors as potential targets for novel antidepressants
2018
·
Shigeyuki Chaki
, Kenichi Fukumoto
·
Current Opinion in Pharmacology
·
34
Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants
2015
·
Shigeyuki Chaki
, Kenichi Fukumoto
·
Pharmaceuticals
·
33
PDF
Prostanoid EP1 receptor antagonist reduces blood–brain barrier leakage after cerebral ischemia
2010
·
Ken-ichi Fukumoto
, Norio Takagi
, et al.
·
European Journal of Pharmacology
·
31
Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine
2019
·
Shigeyuki Chaki
, Kenichi Fukumoto
·
International Journal of Molecular Sciences
·
30
PDF
Involvement of serotonergic system in the effect of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test
2014
·
Kenichi Fukumoto
, Shigeyuki Chaki
·
Journal of Pharmacological Sciences
·
29
PDF
Targeting of Metabotropic Glutamate Receptors for the Development of Novel Antidepressants
2019
·
Shigeyuki Chaki
, Hiroyuki Koike
, et al.
·
Chronic Stress
·
19
PDF
Preclinical pharmacological profiles of vornorexant, a novel potent dual orexin receptor antagonist
2025
·
Hirohiko Hikichi
, Yuichi Tokumaru
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
13
PDF
(2R,6R)-Hydroxynorketamine, A Metabolite of Ketamine: The Antidepressant Actions and the Mechanisms
2021
·
Kenichi Fukumoto
, Ronald S. Duman
·
Contemporary clinical neuroscience
·
2
Hyperactivity in Basolateral Amygdala May Contribute to the Neural Circuit Pathology in Treatment-resistant Depression Model
2025
·
*Kiyoshiro Fukui
, Takuya Kawada
, et al.
·
The International Journal of Neuropsychopharmacology
·
1
PDF
The Efficacy of the Novel 5-ht1a Receptor Agonist Dsp-1181 on Obsessive-compulsive Disorder Like Behavior in a Mouse Model of Optogenetic Neural Modulation
2025
·
*Fumiaki Sato
, Yusuke Nagano
, et al.
·
The International Journal of Neuropsychopharmacology
PDF
Show more works
View as search
Works count:
22
Citation count:
1,560
H-index:
18
I10-index:
19
Year
Topic
Type